Drugs / Autologous bone marrow-derived mesenchymal stem cells
Autologous bone marrow-derived mesenchymal stem cells
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT03838250 | Jun 2019 → Mar 2021 | alcoholic liver cirrhosis | Pharmicell Co., Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT03361631 | Jun → Jul 2018 | erectile dysfunction, type 1 diabetes mellitus | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| Phase 1 | NCT01162915 | Jul 2010 → May 2014 | spinal cord injury | TCA Cellular Therapy | Suspended | No outcome recorded Stop: Business |
| Phase 1 | NCT01751282 | Jun 2010 → Jun 2015 | chronic ulcer of skin | Roger Williams Medical Center | Terminated | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01461720 | Mar 2012 → Dec 2015 | middle cerebral artery infarction | National University of Malaysia | Unknown | No outcome recorded |
| Phase 2 | NCT01459640 | Mar 2011 → Mar 2014 | osteoarthritis | National University of Malaysia | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04735185 | Sep → Nov 2025 | chronic pain syndrome, lumbar disk degenerative disorder | Johns Hopkins University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous bone marrow-derived mesenchymal stem cells | “The purpose of this study is to determine the effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) in the treatment of non-healing wounds.” NCT01751282 ↗5“intradiscal injection of autologous bone marrow-derived mesenchymal stem cells from bone marrow aspirate of the posterior ilium” NCT04735185 ↗ |
| Known as | Cellgram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03838250 ↗ |
| Known as | MSCs | “The purpose of this study is to determine the effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) in the treatment of non-healing wounds.” NCT01751282 ↗ |
| Modality | Cell therapy | “Infusion of autologous bone marrow-derived mesenchymal stem cells.” NCT01162915 ↗ |
| Route | Intrathecal | “Intrathecal infusion of a single dose of ex vivo expanded MSC.” NCT01162915 ↗ |